addiction
Chinese Heroin vs. Canadian Cannabis – Cannabis | Weed | Marijuana
Published
1 year agoon
By
admin
In Canada, especially in Vancouver, British Columbia, it’s a battle between Chinese heroin (fentanyl) and Canadian cannabis. Outside the allowable parameters of the debate is the solution: how cannabis is used for rehabilitation and how to safely self-rehab with cannabis usage.
You can quit meth with cannabis rehab. Rehab for alcohol should include cannabis-based medicines. Or forget the rehab centre altogether.
Safely self-rehab with cannabis usage from the comfort of your home.
People are struggling with substance use. It’s not just people living on the street overdosing on Chinese heroin.
Many overdoses have been in homes where the victim is a regular working Joe or Jane enjoying their drug of choice after work. A tainted supply is poisoning them.
The obvious solution is to legalize all drugs and deal with the consequences as they arise.
The only other alternative is the status quo: A tainted street drug supply killing people. And big pharma profiting from a “safe supply” funded by taxpayers and immune to criticism because of “Science” and “Public Health.”
Of course, there is another alternative. A made-in-Canada solution that:
- Empowers individuals to overcome their substance use problems
- Benefits Canadians economically and has little impact on the taxpayer
- Is a safer alternative to handing out free hydromorphone pills
Just as we look at specific parts of history and think, “How could they be so dumb?” Future historians will say the same about this period.
We have records amount of people overdosing on Chinese heroin. The obvious solution is to legalize all drugs so there’s a regulated supply. As well as looking into how cannabis is used for rehabilitation.
But these aren’t conversations “public health” wants to have.
How Cannabis is Used for Rehabilitation
“Aren’t you just replacing one addiction with another?” is the common complaint about cannabis rehabilitation, especially self-rehab cannabis use.
But the very idea is patently absurd.
Human beings are creatures of habit. If you give up one habit, you’ll fill in the gaps with another. It’s impossible to be human without having habits. The key is to form habits that are healthy and make life worthwhile.
And suppose “public health” is right about cannabis and other drugs. Let’s give them the benefit of the doubt.
Isn’t withdrawing from opioids far worse than doing the same with cannabis? Would you rather see people living on the street overdosing from Chinese heroin or blazed out of their minds on potent cannabis?
Does it not make sense to use cannabis as an “addiction medicine” until the person is free of harder drugs? Then, they can focus on eliminating their cannabis habit. (If they so choose).
That’s the essence of how cannabis is used in rehabilitation. It is part of the “harm reduction” paradigm doctors and researchers take seriously.
Withdrawing from opioids, meth, cocaine, etc., is painful. Cannabis alleviates pain and has no lethal overdose. Why is this even a debate?
The fact that “public health” still casts shadows over medical cannabis (and smoking cannabis) is criminal in the face of the opioid crisis.
Regarding Chinese heroin vs. Canadian cannabis, many in public health are doing more harm than good with their ideological anti-cannabinoid stance.
Public health will claim there needs to be more research. But as we’ll see, they’re just not looking hard enough. Or perhaps they don’t want to see the evidence even when presented right to them.
Safely Self-Rehab with Cannabis Usage?
It’s not just Chinese heroin (fentanyl) vs. Canadian cannabis. You can quit meth with cannabis rehab and overcome problematic alcohol drinking with cannabis.
You can even overcome “behavioural addictions” like sex, porn, gambling, video games, or excessive phone usage with cannabis.
And you can safely self-rehab with cannabis usage.
Many believe rehabilitation (or rehab) is a structured and therapeutic process involving the latest medical, psychological, and social interventions to help individuals stop using drugs.
But not all rehabs are created equal. Some look for underlying causes and have the patient develop skills and support systems to maintain a drug-free lifestyle.
Others focus on preference changes. Some focus on behavioural therapy, while others provide a cocktail of pharmaceuticals as the solution.
The idea of “self-rehab” is not recognized among the “addiction experts.” There is room for “self-recovery” and “self-treatment,” but the experts insist on their professional help.
To be fair, some drugs require a physical detox. That isn’t something you want to self-administer.
But beyond physical detoxification, what good are the “addiction experts” populating various rehab centres?
Without their help (so goes the argument), an individual is prone to “relapse” since they don’t have the “tools” to manage “cravings” and “triggers.”
But this is all made-up language to describe habits.
“Addiction experts” have built up the allure of drugs so that, when they tell a patient they must never touch it again, they’re basically saying: “You’re going to have a supermodel in your bed every night for the rest of your life. But you can’t touch her.“
A better approach would dispel the magic of Chinese heroin (or meth or alcohol). Ideally, the patient goes to bed feeling like not having the drug in their system is like sleeping with a supermodel.
Safely Self-Rehab with Cannabis Usage
No matter the drug or activity, forgoing something you’ve made a habit out of is hard, especially at night when you’re trying to sleep.
That’s why many former “hard” drug users find relief with cannabis. It takes the edge off the opioid (or meth, alcohol, etc.) withdrawals and helps them sleep.
And once they’re free of the Chinese heroin, if they so choose, they can stop cannabis use as well. Aside from insomnia or boredom, there aren’t many cannabis withdrawal symptoms to watch out for.
Suppose you view your cannabis usage as an addiction medicine you will eventually wean off from. In that case, you probably won’t feel any withdrawal from cannabis at all.
Our culture tends to conflate what drugs do to the brain and body with what they do to the mind. And so far, research suggests drugs do not affect the mind.
Drugs change our physiological state. No one denies that. Cannabinoid or opioid receptors get activated; ethanol crosses the blood-brain barrier.
But the mind is entirely metaphysical. Often, we interpret the feeling in our brain and body as somehow changing the content of our thoughts. But that’s cultural conditioning reinforced by “public health” and “addiction experts.”
Once you separate your mind from your body, framing drug habits as choices becomes easier to manage. To the point that, if you so choose, you can moderate your use of Chinese heroin.
Chinese Heroin vs. Canadian Cannabis
This is what “public health” fails to understand.
Someone living on the street doing Chinese heroin isn’t doing it just for the physical effects. They likely have some underlying condition that they believe fentanyl is helping with.
And “addiction experts” are right there to cheer them on. Believing that fentanyl is helping, just not in the proper way.
If you want to safely self-rehab with cannabis usage, it’s best to throw away this paradigm completely.
Drugs can’t relieve you from your thoughts. All they can do is affect your brain and body, which your autonomous mind interprets as relief.
So, if you’re physically withdrawing from Chinese heroin, then the physical effects of cannabis are a relief. But if you’re tempted to gamble, for example, and you use cannabis to “open up the third eye” and think of the situation objectively – that’s technically magic.
You’ve just interpreted the effects of cannabis to help you think through a problem. And there’s a good reason for it.
THC is like the runner’s high. It’s relaxing, and when you’re physically relaxed, your mind becomes tranquil. New ideas sprout up, and you make connections you previously never noticed.
You can achieve this effect from meditation or an intense workout. But cannabis is like an on-demand runner’s high without exerting yourself. No wonder it’s popular, especially among people trying to get off harder drugs.
Chinese Heroin vs Canadian Cannabis: A Made in Canada Solution
As mentioned, there is a Made-in-Canada solution to the opioid crisis. And it doesn’t involve handing out more opioids.
In a double-blind, randomized, placebo-controlled trial, researchers found CBD cannabis helped alleviate the withdrawal symptoms of heroin users.
Unlike observational studies correlating two or more variables, an RCT demonstrates cause and effect.
Other (not as rigorous) studies have found similar conclusions in cocaine, meth, and tobacco users. CBD helps reduce cravings and withdrawal symptoms.
Fortunately, Canada has a cannabis and hemp industry. We can mass produce CBD flower to the point that it’s less than a dollar per gram.
As one study put it,
Cannabinoid therapeutics offer further benefits of being available in multiple formulations, are low in adverse risk potential, and may easily be offered in community-based settings, which may add to their feasibility as interventions for – predominantly marginalized – crack-cocaine user populations.
But in Vancouver and other ravished areas of B.C., community-based cannabis clubs (like the Victoria Cannabis Buyers’ Club) are targeted by health authorities as criminal.
Canada can reverse course on the opioid crisis. We can tap into a – literal – homegrown solution and set an example for the world.
Instead, “public health” targets the community-based cannabis activists who are actually helping. Meanwhile, they defend Big Pharma’s profiteering under the guise of “safer supply.”
Any criticism of their ideology is considered “hate” and “misinformation.” But how could something be evidence-based if the program is immune to criticism?
How Cannabis is Used for Rehabilitation
We’ve outlined how cannabis is used for rehabilitation and the science behind it.
Every overdose death is blood on the hands of public health bureaucrats. We have the solution at our fingertips. In some places, we even have the political willpower.
The problem is these unelected, anti-Enlightenment, philosophically-inept “public health” bureaucrats who, since 2020, have become drunk on their own power.
The only way to solve the opioid crisis in the long term is to strip these people of their power and prestige. They are the priests and nuns of a civic religion called Science™.
Don’t let the name confuse you with the scientific method. The two couldn’t be further apart.
You may like
-
Top 5 Delta 9 Edibles That Actually Work and Taste Delicious
-
The Latest in DEA Shenanigans? The Federal Agency Punts Marijuana Hearings into 2025
-
Dutch police find gnome made of MDMA during drug bust
-
Rejected applicants sue Minnesota over marijuana social equity licensing process
-
4 Ways Marijuana Can Help You Have A Better Thanksgiving
-
Can Big Alcohol Help The Cannabis Industry
addiction
Can Psychedelics Treat Addiction and Alcoholism?
Published
2 months agoon
September 13, 2024By
admin
Psychedelics, once associated primarily with counterculture and recreational drug use, are now being seriously studied for their therapeutic potential in treating drug addiction and alcoholism. Recent research has shown that substances like psilocybin, LSD, and ayahuasca may have profound benefits for individuals struggling with Alcohol Use Disorder (AUD) and substance use disorders (SUD). These compounds are being reconsidered not only for their ability to induce altered states of consciousness but also for their potential to address addictive behaviors and psychological trauma at the root of addiction.
Psilocybin’s Efficacy in Treating Alcohol Use Disorder
One groundbreaking study, conducted at New York University and Johns Hopkins University, demonstrated the potential of psilocybin in treating Alcohol Use Disorder (AUD). The researchers focused on individuals with severe AUD, administering two doses of psilocybin in conjunction with psychotherapy. The results were notable: participants reported a 50% reduction in heavy drinking days over an eight-month period, with some maintaining abstinence from alcohol even a year later.
The trial followed a double-blind, randomized approach and found that the therapeutic effects of psilocybin were superior to those observed with placebo treatments. Dr. Michael Bogenschutz, a lead researcher in the study, emphasized the importance of the psychedelic experience itself in breaking the cycle of addiction. Psilocybin appears to help patients break through entrenched mental patterns, often revealing deeper emotional connections and realizations that drive more meaningful behavior change.
How Psychedelics Influence the Brain to Combat Addiction
The mechanism behind the efficacy of psychedelics in treating addiction is thought to involve neuroplasticity, or the brain’s ability to reorganize and form new connections. By interacting with serotonin 2A receptors, particularly in the prefrontal cortex and default mode network, psychedelics can enable profound shifts in perception and cognition. These altered states of consciousness allow individuals to confront underlying psychological issues, such as trauma or negative emotional patterns, which are often at the core of addictive behaviors.
Many individuals undergoing psychedelic-assisted therapy report experiencing a “reset” of their mental state, facilitating a more open mindset that helps them engage with therapy in a deeper, more effective way. This contrasts with traditional addiction treatments, such as methadone or buprenorphine, which primarily manage withdrawal symptoms but do not address the psychological components of addiction.
LSD and Its Potential in Addiction Treatment
LSD (lysergic acid diethylamide) has also shown promise in treating addiction, particularly alcoholism. Early studies from the 1950s to the 1970s suggested that LSD might help reduce alcohol dependency, but interest in this line of research waned due to regulatory crackdowns on psychedelic research. However, more recent studies have reignited interest in LSD’s therapeutic potential.
A meta-analysis published in the Journal of Psychopharmacology reviewed data from six trials involving over 500 patients. It concluded that a single high dose of LSD, administered in a therapeutic setting, was associated with a significant reduction in alcohol consumption. The study found that LSD’s psychedelic effects could lead to lasting changes in personality traits, such as openness and emotional resilience, which are crucial for overcoming addiction.
Ayahuasca and Addiction Recovery
Ayahuasca, a traditional Amazonian brew containing DMT (dimethyltryptamine) and MAO inhibitors, has been the focus of recent studies examining its potential to treat addiction. Researchers have found that ayahuasca’s intense psychoactive properties, combined with its ability to facilitate introspection and emotional healing, may help individuals overcome opioid and stimulant addiction. A study published in Frontiers in Pharmacology noted that ayahuasca led to significant improvements in mental health and reductions in addictive behaviors.
Ayahuasca ceremonies, often conducted in a spiritual context, have been shown to promote healing through vivid and sometimes challenging visions. Participants often report gaining insights into the underlying causes of their addiction, leading to long-lasting psychological benefits.
Challenges in Psychedelic-Assisted Therapy
While the results of these studies are promising, the use of psychedelics in treating addiction is not without challenges. For one, the psychedelic experience itself can be unpredictable, and not all patients experience the profound mystical or emotional breakthroughs associated with positive outcomes. The effectiveness of psychedelic-assisted therapy appears to be linked to the quality of the therapeutic environment and the expertise of the facilitators, meaning that careful preparation and integration are key to success.
Moreover, while psychedelics like psilocybin and LSD do not appear to be physically addictive, their use must still be carefully regulated to prevent potential psychological risks, such as hallucinations, anxiety, or psychotic episodes in vulnerable individuals. Current research emphasizes the need for controlled settings where trained therapists can guide patients through their psychedelic experiences.
Ongoing Research and Future Directions
Given the promising early results, psychedelic research is entering a new phase, with larger clinical trials currently underway. The National Institutes of Health (NIH) recently allocated $2.4 million to explore the use of psychedelics in treating methamphetamine addiction, further solidifying the role of psychedelics in addiction therapy. Similarly, ongoing studies are looking into psilocybin’s potential to treat opioid addiction and cocaine dependence, conditions that have been notoriously difficult to treat with conventional methods.
As research progresses, it is likely that psilocybin, LSD, and other psychedelics will become more widely recognized as effective tools for addiction treatment. While more research is needed to fine-tune these therapies and better understand their long-term effects, early indications are that psychedelics could revolutionize addiction and alcoholism treatments in the coming decades.
Conclusion
Psychedelics like psilocybin, LSD, and ayahuasca are emerging as potential breakthrough therapies for treating drug addiction and alcoholism. By promoting neuroplasticity and addressing the psychological roots of addiction, these substances offer an alternative to traditional addiction treatments, which often focus on managing symptoms rather than curing the disease. With ongoing research and increasing clinical trials, psychedelic-assisted therapy may become an essential tool in the fight against substance use disorders, offering hope to millions of people who struggle with addiction, such as alcoholism.
Sources
Johns Hopkins Medicine: Psychedelics in Addiction Treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry
National Institutes of Health (NIH) Research on Psychedelics
Frontiers in Pharmacology: Ayahuasca for Addiction Recovery
JAMA Otolaryngology – Head & Neck Surgery
Related
addiction
The Evolving Opioid Crisis in Europe: Heroin and Synthetic Threats
Published
2 months agoon
September 12, 2024By
admin
The opioid crisis in Europe is growing in complexity, with heroin continuing to dominate the market while synthetic opioids, such as fentanyl and its analogs, emerge as potent new threats. The 2024 EU Drug Markets Report, released by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol, provides a comprehensive analysis of the heroin and synthetic opioid market, detailing the health risks, evolving trafficking routes, and potential future challenges.
Heroin in Decline? Why Synthetic Opioids Pose a New Threat in Europe
Heroin’s Ongoing Impact in Europe
Heroin remains the most commonly used illicit opioid in Europe, with an estimated 1 million high-risk opioid users. The European heroin market is valued at over €5.2 billion annually, indicating the persistent demand for this drug. In 2021, EU countries seized 9.5 tonnes of heroin, the largest quantity in 20 years. These figures underscore the strong presence of heroin in Europe, despite the introduction of harm reduction programs aimed at curbing opioid use.
The health consequences of heroin use are severe. In 2021, opioids were responsible for three-quarters of Europe’s 6,000 drug-related overdose deaths, with heroin being a leading factor. Long-term users are aging, adding complexity to public health strategies, as older opioid users present with more chronic health problems.
Afghanistan’s Opium Ban: Future Implications for Heroin Supply
Nearly all heroin consumed in Europe is derived from opium produced in Afghanistan. However, Afghanistan’s opium production has seen a dramatic decline following the Taliban’s 2022 ban on poppy cultivation, which led to a 95% reduction in production by 2023. While the immediate impact on heroin availability in Europe has been minimal, the report warns that a sustained ban could lead to future heroin shortages. Such shortages could open the door for synthetic opioids to dominate the market.
The decline in Afghan opium cultivation from 233,000 hectares in 2022 to just 10,800 hectares in 2023 has raised concerns about the future of heroin availability in Europe. Should the Taliban continue to enforce the ban, experts believe the resulting heroin scarcity could increase the use of more potent and dangerous synthetic opioids, exacerbating the public health crisis.
The Rise of Synthetic Opioids: Fentanyl and its Analogues
Synthetic opioids, such as fentanyl, are becoming more prevalent in the European drug market. These substances are far more potent than heroin, and even small doses can lead to fatal overdoses. The 2024 report highlights how these synthetic opioids are contributing to a growing number of overdose deaths and hospital emergencies across Europe. In countries such as Estonia and Sweden, fentanyl is responsible for a significant proportion of drug-related deaths.
Fentanyl analogs are particularly concerning because they can be mixed with other drugs like heroin or cocaine, often without the user’s knowledge. The increasing presence of these synthetic opioids is a major public health concern, as traditional harm reduction measures, such as naloxone distribution and needle exchange programs, are less effective against these more potent substances.
Changing Trafficking Routes and Criminal Networks
Traffickers are increasingly adapting their methods in response to heightened enforcement measures and geopolitical developments. The traditional Balkan route, which brings heroin through Turkey and Bulgaria into Europe, has seen increased enforcement and stricter border controls, prompting traffickers to shift towards alternative routes.
The Southern route is becoming more prominent, with significant heroin shipments passing through Iran and Pakistan before reaching Europe via major seaports. The United Arab Emirates (UAE) has emerged as a key transshipment hub for heroin, providing both logistical support and avenues for money laundering. Meanwhile, the ongoing Russia-Ukraine war has prompted criminal networks to modify their trafficking routes, further complicating law enforcement efforts.
Public Health and Harm Reduction Efforts
Harm reduction strategies have had some success in mitigating the impact of opioid use in Europe. Programs such as opioid substitution therapy (OST) and needle exchange have helped reduce the number of new users injecting heroin, thereby lowering the risks of HIV and hepatitis C transmission. However, the growing prevalence of synthetic opioids poses new challenges. These potent drugs often require stronger overdose prevention measures, such as fentanyl test strips and more widespread access to naloxone, an opioid antagonist used to reverse overdoses.
Additionally, the report notes the importance of expanding data collection and improving early warning systems to monitor emerging trends in opioid use and trafficking. These systems allow public health authorities and law enforcement to respond more quickly to new synthetic opioids entering the market.
Challenges in Treating Opioid Addiction
Treatment for opioid addiction, particularly heroin, is evolving. Europe’s aging population of opioid users presents new challenges, as older users are more likely to have complex medical conditions. Many long-term users require not just drug treatment but also social support and healthcare for chronic conditions related to long-term substance use. Furthermore, gender-specific issues are emerging, as women who use opioids face more barriers to accessing treatment and are more likely to present with co-occurring psychological or social issues.
Conclusion
The opioid crisis in Europe is evolving, with heroin still posing a significant threat to public health, while synthetic opioids like fentanyl are emerging as an even more dangerous force. The reduction in Afghan opium production and the shifting trafficking routes complicate the landscape further. To tackle this complex issue, Europe must continue to invest in harm reduction, international cooperation, and early warning systems to prevent more overdose deaths and manage the changing face of the opioid market. Without a coordinated response, Europe risks facing an even more devastating public health crisis in the coming years.
Related
The fact that some people are eating dogs and cats is a highly sensitive topic that crosses cultural, social, and ethical boundaries. In many regions, these animals are consumed due to cultural traditions and necessity, while in other cases, drug-induced behavior may lead individuals to engage in extreme or unusual dietary practices. This article aims to explore the distinction between cultural norms and the desperate, erratic behaviors driven by substance abuse, focusing on the need for cultural sensitivity while addressing harmful behavior.
When Culture Meets Addiction: Who Is Eating Dogs and Cats?
Cultural Practices and the Consumption of Non-Traditional Animals
In some parts of Asia and Africa, the phenomena of eating dogs and cats has historical roots that are tied to both cultural traditions and the availability of resources. In these regions, the eating of non-traditional animals is a normalized practice and is not connected to drug-fueled behavior.
- Cultural Normalcy: In regions such as South Korea, China, and Vietnam, dogs have historically been consumed as part of traditional cuisines. This practice is not driven by addiction or desperation but by cultural norms that view these animals as a food source rather than pets.
- Food Scarcity: In some communities, especially in impoverished or rural areas, consuming non-traditional animals like dogs or cats is a practical response to food scarcity. The decision to eat these animals is based on survival rather than personal preference or altered judgment.
Drug-Induced Dietary Choices: When Addiction Leads to Extreme Behaviors
In contrast to cultural practices, there are cases where individuals under the influence of drugs engage in extreme or bizarre behaviors, such as eating dogs and cats… This behavior is driven by impaired judgment, psychosis, or desperation caused by addiction, and often occurs in isolated or marginalized communities.
- Methamphetamine and Erratic Behavior: Meth users are known to exhibit extreme and irrational behaviors, including eating animals they wouldn’t normally consider food. Meth-induced psychosis can blur the lines between reality and hallucination, leading to bizarre dietary choices such as consuming pets or strays.
- Desperation from Heroin Addiction: Heroin addicts, especially those living in extreme poverty, may consume non-traditional animals out of necessity. Chronic malnutrition and impaired judgment, combined with isolation from society, can drive addicts to make choices they wouldn’t otherwise consider.
Understanding the Cultural vs. Drug-Fueled Divide
It’s crucial to differentiate between cultural practices and behaviors driven by addiction when discussing the consumption of non-traditional animals. Respecting cultural practices while addressing the harmful impacts of substance abuse requires a nuanced understanding of these different contexts.
- Cultural Sensitivity: When discussing the consumption of non-traditional animals, especially in regions where this practice is accepted, it is important to approach the subject with cultural sensitivity. Condemning these practices without understanding their historical and social context can perpetuate stereotypes and breed intolerance.
- Addressing Addiction-Related Behaviors: Conversely, when the consumption of animals like dogs and cats is tied to addiction, the focus should be on treating the root causes of drug abuse rather than criminalizing individuals. Rehabilitation, mental health support, and access to food resources are critical in preventing desperate behaviors.
Ethical Considerations and Animal Welfare
Regardless of whether the consumption of non-traditional animals is driven by culture or desperation, the ethical treatment of animals is a key concern. The dog and cat meat industries have come under scrutiny for their inhumane treatment of animals, and organizations worldwide are working to promote animal welfare and ethical eating practices.
- Animal Rights in Cultural Contexts: While respecting cultural traditions, animal rights organizations are increasingly advocating for more humane practices within these industries. Campaigns to ban or reduce the consumption of dog and cat meat have gained traction, with a focus on reducing cruelty and promoting alternative food sources.
- Animal Cruelty and Drug Addiction: In cases of drug-induced behaviors, the animals involved often suffer from neglect or harm. Providing support for addicts and ensuring animals are removed from harmful environments can help mitigate this issue.
How to Approach the Issue Globally
Addressing the issue of non-traditional animal consumption, whether cultural or drug-fueled, requires a global approach that balances respect for cultural practices with the promotion of humane treatment for animals. Public health initiatives and cultural sensitivity training can help bridge the gap between different viewpoints while ensuring that animals and people alike are treated with dignity.
- Promoting Cultural Understanding: Efforts to educate the public on the cultural contexts of eating non-traditional animals can help reduce prejudice and promote more respectful global dialogues. Cultural exchange programs and educational campaigns can provide a more nuanced view of these practices.
- Addressing Substance Abuse: On the other hand, combatting the desperation and irrational behavior caused by addiction requires investments in mental health, addiction treatment, and public welfare systems. Providing addicts with support, housing, and access to food can reduce the likelihood of harmful or extreme behaviors.
Conclusion
While the consumption of non-traditional animals like dogs and cats may be culturally accepted in some regions, drug-induced behaviors that lead to similar actions must be understood in a different light. It’s important to address addiction-related behavior with compassion, focusing on rehabilitation and support rather than punishment. At the same time, promoting animal welfare and humane practices in regions where these animals are consumed can create a more ethical global community. By approaching these issues with respect for cultural diversity and a commitment to reducing harm, both animals and humans can benefit.
Related
Top 5 Delta 9 Edibles That Actually Work and Taste Delicious
The Latest in DEA Shenanigans? The Federal Agency Punts Marijuana Hearings into 2025
Dutch police find gnome made of MDMA during drug bust
Rejected applicants sue Minnesota over marijuana social equity licensing process
4 Ways Marijuana Can Help You Have A Better Thanksgiving
Can Big Alcohol Help The Cannabis Industry
California Appeals Court Rejects Marijuana Grow Permit, Citing Federal Illegality
Expert Lighting Tips For Successful Indoor Growing Weed
Acne And CBD: Exploring Alternative Dermatological Solutions
Can I Gift Marijuana This Holiday Season?
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing11 months ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse